What are the specific drugs for treating small cell lung cancer? Different drugs are used at different times

There is currently no specific treatment for small cell lung cancer. Small cell lung cancer is a special disease that is very different from lung adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Small cell lung cancer can only be treated with comprehensive treatments such as radiotherapy and chemotherapy, and surgical treatment is less effective. For the treatment of small cell carcinoma, conventional drugs such as etoposide + cisplatin have good efficacy, but recurrence or drug resistance may also occur.

In daily life, small cell lung cancer is becoming more and more common, endangering the lung health of many friends and disrupting the daily life of patients. During the onset of the disease, the patient's cough is particularly severe, which also hinders the patient's breathing. Friends need to understand the occurrence of small cell lung cancer and clearly understand the specific drugs for treating this disease. The following is an introduction to what are the specific drugs for treating small cell lung cancer?
Small cell lung cancer is a terrible disease. Many friends have symptoms of the disease, which seriously damages people's lung health, causes discomfort to patients, and also affects normal life. If a patient has a small cell lung cancer, they need to take related drugs to help cope with the disease. If the patient's tumor recurs within 3 months, drugs such as docetaxel, paclitaxel, gemcitabine, and ifosfamide can be used.
If the patient's tumor recurrence is more than three months, drugs such as irinotecan, topotecan, gamcitracin, paclitaxel, and novelbine need to be used. For patients whose tumor recurrence is more than six months, the first-line treatment plan needs to be maintained.
Chemotherapy is recommended for small cell lung cancer. Commonly used chemotherapy drugs include etoposide, cisplatin, carboplatin, etc. Chemotherapy drugs for recurrent small cell lung cancer include paclitaxel, docetaxel, irinotecan, cyclophosphamide, doxorubicin, and cyclophosphamide. In most time-limited small cell lung cancers, despite the acute and chronic toxicity of chemoradiotherapy, etoposide + platinum chemotherapy combined with synchronous radiotherapy can still be considered to reduce the local treatment failure rate and improve the survival rate.
After reading the relevant content, patients learned about the specific drugs for treating small cell lung cancer. It is recommended that they pay attention to changes in their lungs, carefully understand the relevant knowledge of small cell lung cancer, and understand the above-mentioned treatment drugs in detail. If the lungs become ill, it is necessary to start treatment for the disease as soon as possible and maintain a good attitude.